Polymorphic Variations in VDR Gene in Saudi Women with and Without Polycystic Ovary Syndrome (PCOS) and Significant Influence of Seven Polymorphic Sites on Anthropometric and Hormonal Parameters

Summary Background: This study was designed to evaluate the associations between vitamin D receptor (VDR) gene polymorphisms and biochemical characteristics of Saudi women with polycystic ovary syndrome (PCOS). Methods: Serum levels of LH, FSH, and Vitamin D were measured in 33 women: 16 patients and 17 normal controls (18 to 36 years). DNA was extracted and used for sequencing of the exons of VDR gene using ABI PRISM 3730xi Genetic Analyzer. Results: Weight, BMI, Vit D, LH and FSH levels were higher in the PCOS patients compared to control group, where Vit D level correlated positively and significantly with FSH, in the control, but showed a negative and non-significant correlation in the PCOS patients. Sequencing results showed extensive polymorphisms in both groups, but the differences in the frequencies were not significant. Demographic and hormonal parameters were compared in the different genotypes of the SNPs. Significant differences were ob served in the values of the studied parameters in rs11168276, rs11168266, rs3858733, rs121909790, rs11168265 and rs731236. Vitamin D level was influenced significantly by the genotypes of rs11168265 (AA) (p=0.008), rs11168276 (AA; p=0.018) and rs731236 (CC; p=0.024). Conclusion: Vitamin D deficiency does not associate with PCOS in Saudi females. Several SNPs are identified in the VDR gene, in normal and PCOS females, but there is no difference in their frequencies between the two groups. The results show that polymorphism in VDR gene influences certain anthropometric and hormonal parameters in PCOS patients. Further detailed studies are required to confirm the associations between VDR and PCOS.

[1]  F. Stepko,et al.  As , 2020, Definitions.

[2]  S. Shivaji,et al.  Vitamin D receptor gene polymorphisms and risk of polycystic ovary syndrome in South Indian women , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[3]  J. Souberbielle,et al.  There is no association between vitamin D status and characteristics of central precocious puberty in girls , 2017, European Journal of Pediatrics.

[4]  Yali Lv,et al.  VDR Gene variation and insulin resistance related diseases , 2017, Lipids in Health and Disease.

[5]  P. Collinson.  Laboratory Medicine is Faced with the Evolution of Medical Practice , 2017, Journal of medical biochemistry.

[6]  S. Jelić,et al.  Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease , 2017, Journal of medical biochemistry.

[7]  A. Milewicz,et al.  Classic PCOS phenotype is not associated with deficiency of endogenous vitamin D and VDR gene polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), rs10735810 (FokI): a case–control study of lower Silesian women , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[8]  K. Majidzadeh-A,et al.  Association of vitamin D receptor gene variants with polycystic ovary syndrome: A case control study , 2015, International journal of reproductive biomedicine.

[9]  A. El-Shal,et al.  Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome , 2013, Molecular Biology Reports.

[10]  M. Bagheri,et al.  Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk , 2013, International journal of fertility & sterility.

[11]  I. Rad,et al.  Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women. , 2012, Maedica.

[12]  B. Obermayer-Pietsch,et al.  Vitamin D and fertility: a systematic review. , 2012, European journal of endocrinology.

[13]  D. Bikle.  Vitamin D metabolism and function in the skin , 2011, Molecular and Cellular Endocrinology.

[14]  J. Horowitz,et al.  Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. , 2011, Nitric oxide : biology and chemistry.

[15]  A. Wallace,et al.  Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. , 2011, Metabolism: clinical and experimental.

[16]  T. Pieber,et al.  Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. , 2011, European journal of endocrinology.

[17]  M. Zali,et al.  Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome , 2011, Journal of Assisted Reproduction and Genetics.

[18]  Z. Rosenwaks,et al.  Vitamin D Regulates Steroidogenesis and Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) Production in Human Ovarian Cells , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[19]  D. Hurley,et al.  Vitamin D deficiency in adults: when to test and how to treat. , 2010, Mayo Clinic proceedings.

[20]  S. Saha,et al.  A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  Z. Ezabadi,et al.  Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. , 2010, Fertility and sterility.

[22]  T. Pieber,et al.  Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. , 2009, European journal of endocrinology.

[23]  T. Mahmoudi.  Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. , 2009, Fertility and sterility.

[24]  M. Kurdoğlu,et al.  Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome , 2009, Archives of Gynecology and Obstetrics.

[25]  Robert N. Taylor,et al.  Relative Expression of 1,25-Dihydroxyvitamin D3 Receptor, Vitamin D 1α-Hydroxylase, Vitamin D 24-Hydroxylase, and Vitamin D 25-Hydroxylase in Endometriosis and Gynecologic Cancers , 2007, Reproductive Sciences.

[26]  R. Kimmig,et al.  The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[27]  H. Taylor,et al.  Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. , 2005, Molecular endocrinology.

[28]  W. Crowley,et al.  Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. , 2004, The Journal of clinical endocrinology and metabolism.

[29]  A. Uitterlinden,et al.  Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[30]  K. Vijayaraghavan.  Vitamin A deficiency , 2000, The Lancet.

[31]  H. Taylor,et al.  Alteration of maternal Hoxa10 expression by in vivo gene transfection affects implantation , 2000, Gene Therapy.

[32]  T. Moriwake,et al.  Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. , 2000, Endocrinology.

[33]  絹田 恵子.  Vitamin D Is an Important Factor in Estrogen Biosynthesis of Both Female and Male Gonads , 2000 .

[34]  J. Marshall,et al.  Neuroendocrine aspects of polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.

[35]  D. Schoenfeld,et al.  Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[36]  T. Spector,et al.  Vitamin-D-receptor-gene polymorphism and bone loss , 1995, The Lancet.

[37]  J. Eisman,et al.  Prediction of bone density from vitamin D receptor alleles , 1994, Nature.

[38]  Ľ. Stárka,et al.  Effect of calcitonin and 1,25(OH)2-vitamin D3 on the FSH, LH and testosterone secretion at rest and LHRH stimulated secretion. , 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[39]  J. Wadsworth,et al.  POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.

[40]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[41]  H. Pols,et al.  Vitamin D , 1928, Calcified Tissue International.

[42]  D. Edwards.  ROYAL INSTITUTION. June 8, 1832.: LECTURE ON THE HISTORY, ORIGIN, PROGRESS, AND PRESENT STATE, OF LITHOTRIPSY , 1832 .

[43]  G. Risbridger.  Human cell lines as tools of our trade: "laying it on the (cell) line". , 2015, Molecular endocrinology.

[44]  J. Górski,et al.  Effects of streptozotocin-induced diabetes and elevation of plasma FFA on ceramide metabolism in rat skeletal muscle. , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[45]  M. Daghestani,et al.  The Correlation between Anthropometric Measurements, Insulin and Reproductive Hormones in Saudi Females with and without Polycystic Ovary Syndrome , 2008 .

[46]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[47]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[48]  R. Norman,et al.  Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. , 1995, Fertility and sterility.

[49]  H. DeLuca,et al.  Vitamin D-regulated gene expression. , 1993, Critical reviews in eukaryotic gene expression.

[50]  H. Dörr,et al.  Human corticotropin-releasing hormone during pregnancy. , 1989, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[51]  W. Crowley,et al.  Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. , 1988, The Journal of clinical endocrinology and metabolism.